Literature DB >> 28160228

Respiratory gating and multifield technique radiotherapy for esophageal cancer.

Atsushi Ohta1, Motoki Kaidu2, Satoshi Tanabe3, Satoru Utsunomiya4, Ryuta Sasamoto4, Katsuya Maruyama1, Kensuke Tanaka1, Hirotake Saito1, Toshimichi Nakano1, Miki Shioi3, Haruna Takahashi3, Naotaka Kushima3, Eisuke Abe1, Hidefumi Aoyama1.   

Abstract

PURPOSE: To investigate the effects of a respiratory gating and multifield technique on the dose-volume histogram (DVH) in radiotherapy for esophageal cancer. METHODS AND MATERIALS: Twenty patients who underwent four-dimensional computed tomography for esophageal cancer were included. We retrospectively created the four treatment plans for each patient, with or without the respiratory gating and multifield technique: No gating-2-field, No gating-4-field, Gating-2-field, and Gating-4-field plans. We compared the DVH parameters of the lung and heart in the No gating-2-field plan with the other three plans. RESULT: In the comparison of the parameters in the No gating-2-field plan, there are significant differences in the Lung V5Gy, V20Gy, mean dose with all three plans and the Heart V25Gy-V40Gy with Gating-2-field plan, V35Gy, V40Gy, mean dose with No Gating-4-field plan and V30Gy-V40Gy, and mean dose with Gating-4-field plan. The lung parameters were smaller in the Gating-2-field plan and larger in the No gating-4-field and Gating-4-field plans. The heart parameters were all larger in the No gating-2-field plan.
CONCLUSION: The lung parameters were reduced by the respiratory gating technique and increased by the multifield technique. The heart parameters were reduced by both techniques. It is important to select the optimal technique according to the risk of complications.

Entities:  

Keywords:  Dosimetry; Esophageal cancer; Multifield; Organ at risk; Respiratory gating

Mesh:

Year:  2017        PMID: 28160228     DOI: 10.1007/s11604-016-0606-7

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  17 in total

1.  Respiratory gating for liver tumors: use in dose escalation.

Authors:  Raquel Wagman; Ellen Yorke; Eric Ford; Philippe Giraud; Gikas Mageras; Bruce Minsky; Kenneth Rosenzweig
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

2.  Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.

Authors:  Thomas P Kole; Osarhieme Aghayere; Jason Kwah; Ellen D Yorke; Karyn A Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

Review 3.  Radiation dose-volume effects in the heart.

Authors:  Giovanna Gagliardi; Louis S Constine; Vitali Moiseenko; Candace Correa; Lori J Pierce; Aaron M Allen; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 4.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer.

Authors:  Hideomi Yamashita; Satoshi Kida; Akira Sakumi; Akihiro Haga; Saori Ito; Tsuyoshi Onoe; Kae Okuma; Kenji Ino; Masaaki Akahane; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

6.  Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.

Authors:  René W M Underberg; Frank J Lagerwaard; Ben J Slotman; Johan P Cuijpers; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

7.  Correlation of gross tumor volume excursion with potential benefits of respiratory gating.

Authors:  George Starkschall; Kenneth M Forster; Kei Kitamura; Alex Cardenas; Susan L Tucker; Craig W Stevens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

8.  Minimal benefit of respiratory-gated radiation therapy in the management of thoracic malignancy.

Authors:  Eric Hau; Melissa Rains; Lois Browne; Rebecca Muirhead; Roland Yeghiaian-Alvandi
Journal:  J Med Imaging Radiat Oncol       Date:  2013-07-12       Impact factor: 1.735

9.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Satoshi Ishikura; Keiji Nihei; Atsushi Ohtsu; Narikazu Boku; Shuichi Hironaka; Kiyomi Mera; Manabu Muto; Takashi Ogino; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

10.  A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer.

Authors:  René W M Underberg; John R van Sörnsen de Koste; Frank J Lagerwaard; Andrew Vincent; Ben J Slotman; Suresh Senan
Journal:  Radiat Oncol       Date:  2006-03-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.